To assess the potential of CMTM4 as a tumour suppressor, we performed an integrated bioinformatics analysis based on the omic tumour data set from the GEO database to determine the differential expression of CMTM4 across multiple cancers and their corresponding control (normal or non-tumour) tissues at the mRNA level. Here, CMTM4 is linked to neoplasm.